Key facts
- This page summarizes Ann R. Klee's Form 4 filing for Sotera Health Co (SHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 29 May 2024, 16:37.
Ann R. Klee - 24 May 2024 Form 4 Insider Report for Sotera Health Co (SHC)
- Reporting relationship
- Director
- Issuer ticker
- SHC
- Reported as of
- 24 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 May 2024, 16:37:01 UTC
- Prior SEC filing
- 20 May 2024
- Next SEC filing
- 19 May 2025
- Source filing
- View source filing
- Reporting owner signature
- Matthew J. Klaben, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ann R. Klee filed Form 4 for Sotera Health Co (SHC) on 29 May 2024.
Change
- Previous filing in this sequence was filed on 20 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SHC
transaction
Common Stock, $0.01 par value per share ("Common Stock")
Award
- Transaction value
- $0
- Shares
- +20,089
- Change %
- +23%
- Price
- $0.000000
- Shares after
- 106,824
- Date
- 24 May 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These securities consist of 20,089 Restricted Stock Units ("RSUs") that were granted on May 24, 2024, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.
Footnote F2
Consist of 20,089 RSUs and 86,735 shares of Common Stock, including 79,752 shares of vested Common Stock and 6,983 shares of unvested Common Stock. The unvested shares of Common Stock will vest on a daily basis pro rata through May 27, 2025.
SEC remarks
The Power of Attorney for Ms. Klee is filed as an exhibit to the Form 3 filed with the Securities and Exchange Commission on November 20, 2020, which is hereby incorporated by reference.